The University of Antwerp and Multiplicom have developed a sudden cardiac death test called PED MASTR that will be launched globally in September. The test analyzes 51 genes using multiplexed PCR and next-generation sequencing technology.
New Products: Multiplicom's PED MASTR
Premium